These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 31511361)

  • 1. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
    Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
    J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
    Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
    Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
    Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
    Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
    [No Abstract]   [Full Text] [Related]  

  • 5. β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis.
    Wang Y; Huang J; Liu X; Niu Y; Zhao L; Yu Y; Zhou L; Lu L; Yu C
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F1-F8. PubMed ID: 28274926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of Aortic Enlargement Induced by Increased Biomechanical Forces Requires AT1R Inhibition in Conjunction With AT2R Activation.
    Zhou Z; Peters AM; Wang S; Janda A; Chen J; Zhou P; Arthur E; Kwartler CS; Milewicz DM
    Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):459-466. PubMed ID: 30602301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.
    Kusunoki H; Taniyama Y; Rakugi H; Morishita R
    J Am Heart Assoc; 2013 Apr; 2(2):e000103. PubMed ID: 23608606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin Attenuates Organ Fibrosis
    Barsha G; Walton SL; Kwok E; Mirabito Colafella KM; Pinar AA; Hilliard Krause LM; Gaspari TA; Widdop RE; Samuel CS; Denton KM
    Kidney360; 2021 Nov; 2(11):1781-1792. PubMed ID: 35373008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade.
    Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
    Can J Cardiol; 2002 Aug; 18(8):873-83. PubMed ID: 12215750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.
    Chow BS; Koulis C; Krishnaswamy P; Steckelings UM; Unger T; Cooper ME; Jandeleit-Dahm KA; Allen TJ
    Diabetologia; 2016 Aug; 59(8):1778-90. PubMed ID: 27168137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.
    Callera GE; Antunes TT; Correa JW; Moorman D; Gutsol A; He Y; Cat AN; Briones AM; Montezano AC; Burns KD; Touyz RM
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27612496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade.
    Widdop RE; Matrougui K; Levy BI; Henrion D
    Hypertension; 2002 Oct; 40(4):516-20. PubMed ID: 12364356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
    BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
    Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
    Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.
    Jugdutt BI; Menon V
    Mol Cell Biochem; 2004 Jul; 262(1-2):203-14. PubMed ID: 15532725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R2R01: A long-acting single-chain peptide agonist of RXFP1 for renal and cardiovascular diseases.
    Poirier B; Pasquier O; Chenede X; Corbier A; Prigent P; Azam A; Bernard C; Guillotel M; Gillot F; Riva L; Briand V; Ingenito R; Gauzy-Lazo L; Duclos O; Philippo C; Maillere B; Bianchi E; Mallart S; Janiak P; Illiano S
    Br J Pharmacol; 2024 Jul; 181(13):1993-2011. PubMed ID: 38450758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
    Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
    Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
    Kurihara T; Ozawa Y; Shinoda K; Nagai N; Inoue M; Oike Y; Tsubota K; Ishida S; Okano H
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5545-52. PubMed ID: 17122147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
    Hossain MA; Man BC; Zhao C; Xu Q; Du XJ; Wade JD; Samuel CS
    Biochemistry; 2011 Mar; 50(8):1368-75. PubMed ID: 21229994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.